EMvision Medical Devices (ASX:EMV) EBIT : A$-2.69 Mil (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is EMvision Medical Devices EBIT?

EMvision Medical Devices's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$0.41 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.69 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. EMvision Medical Devices's annualized ROC % for the quarter that ended in Dec. 2023 was 66.02%. EMvision Medical Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 113.61%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. EMvision Medical Devices's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.72%.

EMvision Medical Devices EBIT Historical Data

The historical data trend for EMvision Medical Devices's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EMvision Medical Devices EBIT Chart

EMvision Medical Devices Annual Data

Trend

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

-2.96

-3.48

-8.39

-6.09

-3.84

EMvision Medical Devices Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial						-2.02	-4.07	-0.74	-3.10	0.41

Competitive Comparison of EMvision Medical Devices's EBIT

For the Medical Devices subindustry, EMvision Medical Devices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EMvision Medical Devices's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EMvision Medical Devices's EV-to-EBIT falls into.

EMvision Medical Devices EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-2.69 Mil.

EMvision Medical Devices (ASX:EMV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EMvision Medical Devices's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	-12.66 * ( 1 - 131.82% )	/	( (6.62	+	5.584)	/ 2 )
=	4.028412	/	6.102
=	66.02 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11.518	-	0.701	-	( 9.969	-	max(0, 6.037	-	10.234	+	9.969	))
=	6.62

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	11.237	-	0.82	-	( 8.48	-	max(0, 5.28	-	10.113	+	8.48	))
=	5.584

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

EMvision Medical Devices's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	0.822	/	( ( (0.803 + max(-3.044, 0))	+	(0.644 + max(-0.865, 0)) )	/	2 )
=	0.822	/	( ( 0.803	+	0.644 )	/	2 )
=	0.822	/	0.7235
=	113.61 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0	+	0	+	0.265)	-	(0.701	+	0	+	2.608)
=	-3.044

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.017	+	0	+	1.616)	-	(0.82	+	0	+	1.678)
=	-0.865

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

EMvision Medical Devices's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	-2.685	/	155.946
	=	-1.72 %

EMvision Medical Devices EBIT Related Terms

Thank you for viewing the detailed overview of EMvision Medical Devices's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

EMvision Medical Devices (ASX:EMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EMvision Medical Devices Ltd (ASX:EMV) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Epping Road, Suite 4.01, Macquarie Park, NSW, AUS, 2113

Website

https://www.emvision.com.au

EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research, development, and commercialization of medical imaging and diagnostic technology. It is seeking to commercialize a potentially low-cost, portable medical imaging device using electromagnetic microwave imaging for stroke diagnosis and monitoring and other medical imaging needs.

EMvision Medical Devices (ASX:EMV) Headlines

No Headlines